SU
243
+1.57%↑
BAS
46.85
+2.38%↑
AM
324.2
-1.04%↓
REP
22.67
-6.75%↓
EXE.US
107.66
+0.36%↑
SU
243
+1.57%↑
BAS
46.85
+2.38%↑
AM
324.2
-1.04%↓
REP
22.67
-6.75%↓
EXE.US
107.66
+0.36%↑
SU
243
+1.57%↑
BAS
46.85
+2.38%↑
AM
324.2
-1.04%↓
REP
22.67
-6.75%↓
EXE.US
107.66
+0.36%↑
SU
243
+1.57%↑
BAS
46.85
+2.38%↑
AM
324.2
-1.04%↓
REP
22.67
-6.75%↓
EXE.US
107.66
+0.36%↑
SU
243
+1.57%↑
BAS
46.85
+2.38%↑
AM
324.2
-1.04%↓
REP
22.67
-6.75%↓
EXE.US
107.66
+0.36%↑
24h
Current
Min
123.4
Max
129.8
Recommendations | Buy |
|---|---|
12 Months Forecast | +28.5% upside |
Next Earnings | 5 May 2026 |
|---|
By Acuity
43%
57%
48 / 137 Energy
Past performance is not a reliable indicator of future results.
23 Mar 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Read
23 Mar 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Read
23 Mar 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Read
23 Mar 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Read
23 Mar 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Read
23 Mar 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Read
23 Mar 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Read
23 Mar 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Read
23 Mar 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Read
23 Mar 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Read
23 Mar 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Read
23 Mar 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Read
23 Mar 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Read
23 Mar 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Read
23 Mar 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Read
23 Mar 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Read
23 Mar 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Read
23 Mar 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Read
23 Mar 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Read
23 Mar 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Read
23 Mar 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Read
23 Mar 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
23 Mar 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Read
23 Mar 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Read
23 Mar 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Read
23 Mar 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Read
23 Mar 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Read
23 Mar 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Read
23 Mar 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Read
23 Mar 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 165 EUR 28.5%
High 180 EUR
Low 150 EUR
Based on 2 Wall Street analysts offering 12 month price targets forViridien - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
1
Buy
1
Hold
0
Sell
Based on 2 analysts giving stock ratings to Viridien - Dist in the past 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
$